PHIO PHARMACEUTICALS CORP COM NEW

PHIO PHARMACEUTICALS CORP COM NEW is a security (CUSIP 71880W501) tracked across SEC portfolio filings. 23 institutional managers reported $706K on Form 13F as of 2026-06-30; 2 registered fund positions totaling $97K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 23 managers by value.

ManagerLocationValueShares
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$180K147,254
JANE STREET GROUP, LLCNEW YORK, NY$145K119,189
VANGUARD GROUP INCValley Forge, PA$92K87,628
Cetera Investment AdvisersSCHAUMBURG, IL$55K45,000
TWO SIGMA INVESTMENTS, LPNew York, NY$40K32,495
Scientech Research LLCJERSEY CITY, NJ$37K30,032
UBS Group AGZurich, V8$33K26,987
XTX Topco LtdLONDON, X0$30K24,868
NORTHERN TRUST CORPCHICAGO, IL$29K23,758
TWO SIGMA SECURITIES, LLCNew York, NY$19K15,224
CAPTRUST FINANCIAL ADVISORSRALEIGH, NC$12K10,000
CITIGROUP INCNEW YORK, NY$12K11,605
Tower Research Capital LLC (TRC)NEW YORK, NY$9K7,620
MORGAN STANLEYNEW YORK, NY$7K6,000
OSAIC HOLDINGS, INC.PHOENIX, AZ$2K2,000

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$97K0.01%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$50.00%

More